Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Clinical trial NCT04133337 · UNKNOWN

Trial details

NCT number: NCT04133337
Sponsor: Sichuan Cancer Hospital and Research Institute
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Diseases Neoplasms Respiratory Tract Diseases Thoracic Neoplasms Non-small-cell Lung Cancer

Start date: 2019-11-01
Primary completion: 2020-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.